Vyome Holdings Files 8-K
Ticker: HIND · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Vyome Holdings, Inc (HIND) |
| Form Type | 8-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
TL;DR
Vyome Holdings filed a routine 8-K, no major news yet.
AI Summary
Vyome Holdings, Inc. filed an 8-K on September 2, 2025, reporting on other events and financial statements. The company, formerly known as ReShape Lifesciences Inc. and OBALON THERAPEUTICS INC, is incorporated in Delaware and has its principal executive offices in Cambridge, MA. The filing does not disclose specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Vyome Holdings, Inc. is meeting its regulatory reporting obligations. Investors should review the full filing for any specific material events or financial updates.
Risk Assessment
Risk Level: low — The filing appears to be a standard regulatory report without immediate disclosure of significant new risks or events.
Key Players & Entities
- Vyome Holdings, Inc. (company) — Registrant
- ReShape Lifesciences Inc. (company) — Former company name
- OBALON THERAPEUTICS INC (company) — Former company name
- September 2, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Cambridge, MA (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Vyome Holdings, Inc.?
The filing is a Current Report on Form 8-K, reporting on 'Other Events' and 'Financial Statements and Exhibits' as of September 2, 2025.
When was the report filed and what is the earliest event date reported?
The report was filed on September 2, 2025, and the earliest event date reported is also September 2, 2025.
What are the former names of Vyome Holdings, Inc. mentioned in the filing?
The filing states that Vyome Holdings, Inc. was formerly known as ReShape Lifesciences Inc. and prior to that, OBALON THERAPEUTICS INC.
Where are Vyome Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138.
What is the company's state of incorporation and IRS Employer Identification Number?
The company is incorporated in Delaware and its IRS Employer Identification No. is 26-1828101.
Filing Stats: 708 words · 3 min read · ~2 pages · Grade level 11.4 · Accepted 2025-09-02 08:04:58
Key Financial Figures
- $0.001 — registered Common stock, par value $0.001 per share HIND The Nasdaq Capital Marke
Filing Documents
- ea0254874-8k_vyome.htm (8-K) — 37KB
- ea025487401ex99-1_vyome.htm (EX-99.1) — 550KB
- ea025487401ex99-2_vyome.htm (EX-99.2) — 147KB
- ea025487401ex99-3_vyome.htm (EX-99.3) — 185KB
- 0001213900-25-082924.txt ( ) — 5825KB
- hind-20250902.xsd (EX-101.SCH) — 57KB
- hind-20250902_lab.xml (EX-101.LAB) — 506KB
- hind-20250902_pre.xml (EX-101.PRE) — 311KB
- hind-20250902_cal.xml (EX-101.CAL) — 41KB
- hind-20250902_def.xml (EX-101.DEF) — 284KB
- ea0254874-8k_vyome_htm.xml (XML) — 651KB
Financial Statements of Vyome for the quarter ended June 30, 2025
Financial Statements of Vyome for the quarter ended June 30, 2025 99.2 Management's Discussion and Analysis of Financial Condition and Results of Operations of Vyome for the quarter ended June 30, 2025 99.3 Unaudited Pro Forma Condensed Combined Financial Statements 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC; provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Exchange Act for any schedule so furnished. 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VYOME HOLDINGS, INC. September 2, 2025 By: /s/ Venkat Nelabhotla Name: Venkat Nelabhotla Title: President & Chief Executive Officer 2